Introduction {#Sec1}
============

The fungal genus *Stachybotrys* is ubiquitously present in the environment, especially on commodities rich in cellulose, such as straw, wood, and paper as well as gypsum board, and was first isolated from a moldy wallpaper in Prague (Bisby [@CR3]). The occurrence of *Stachybotrys* species has been reported frequently, particularly in water-damaged buildings (Johanning et al. [@CR18]; Jarvis et al. [@CR17]; Bloom et al. [@CR4]). In this context, the species *Stachybotry*s *chartarum* (*atra*) received attention in the 1990s, within cases of building-related illnesses and idiopathic pulmonary hemosiderosis in infants (Etzel et al. [@CR9]; Dearborn et al. [@CR6]; Page and Trout [@CR28]; Pestka et al. [@CR29]). Approximately 150 secondary metabolites from *Stachybotrys* species are known and might be related to the observed adverse human health effects in the cases mentioned above (Jarvis et al. [@CR16]; Hossain et al. [@CR13]). Important representatives are macrocyclic trichothecenes, including the highly toxic satratoxins, atranones, and phenylspirodrimanes (Fig. [1](#Fig1){ref-type="fig"}) (Jarvis [@CR14]). The phenylspirodrimanes occur in considerably higher levels and are therefore designated to be the most characteristic and dominant group of mycotoxins among this genus (Jarvis et al. [@CR15]). Additionally, the latter compounds are produced by the majority of *Stachybotrys* species, whereas the macrocyclic trichothecenes are only produced by *S. chartarum* chemotype S (Andersen et al. [@CR1]).Fig. 1Main classes of *Stachybotrys* metabolites. **a** Macrocyclic trichothecenes (satratoxin H). **b** Atranones (atranone A). **c** Phenylspirodrimanes (stachybotrydial)

Phenylspirodrimanes are part of the group of triprenyl phenols, which in turn belong to the broad group of meroterpenoids. The latter represent natural products whose molecular structures contain moieties originating from the polyketide pathway as well the terpenoid pathway (Geris and Simpson [@CR10]; Matsuda and Abe [@CR25]). This structurally unique class of substances shows a broad diversity of biological activities. For instance, disruption of the complement system, immunotoxicity, neurotoxicity, cytotoxicity, fibrinolysis, and plasminogen activation, as well as antiviral and antiplasmodial activity, have been shown (Sawadjoon et al. [@CR32]; Hasumi et al. [@CR12]; Sasaoka et al. [@CR31]; Wang et al. [@CR33]).

Particularly in the last years, the genus *Stachybotrys* revealed tremendous potential for the isolation of novel meroterpenoid derivatives with remarkable properties concerning biological activity, e.g., inhibitory effects against the dengue virus (Li et al. [@CR19], [@CR20]; Bao et al. [@CR2]; Ma et al. [@CR24]; Chunyu et al. [@CR5]; Ding et al. [@CR7], [@CR8]; Li et al. [@CR22]; Liu et al. [@CR23]; Yin et al. [@CR34], Zhang et al. [@CR35]; Zhao et al. [@CR36], [@CR37], [@CR38]).

In the course of HPLC-MS/MS profiling of secondary metabolites from *Stachybotrys* species, the triprenyl phenol-like compounds stachybotrychromenes A--C (**1**--**3**) (Fig. [2](#Fig2){ref-type="fig"}) were identified as three novel meroterpenoid metabolites. Herein, we describe the isolation and structure elucidation and give first insights into cytotoxicity of these compounds.Fig. 2Chemical structures of the isolated stachybotrychromenes A--C (**1**--**3**) from *S. chartarum*

Materials and methods {#Sec2}
=====================

General experimental procedures {#Sec3}
-------------------------------

Analytical thin-layer chromatography (TLC) was performed with pre-coated silica gel plates (Silica gel 60 F254, Merck, Darmstadt, Germany), and UV irradiation was used for visualization (254 and 360 nm, Herolab, Wiesloch, Germany).

Semi-preparative reversed-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC-UV) was carried out by using a Jasco system (Jasco, Groß-Umstadt, Germany) equipped with a 1-mL sample loop (Rheodyne, CA, USA) at a wavelength of 360 nm with an Agilent Eclipse XDB-C 18 column (250 × 9.4 mm, 5 μm, Agilent, Waldbronn, Germany).

1D and 2D nuclear magnetic resonance (NMR) spectra were recorded at 600 MHz for ^1^H NMR and 150 MHz for ^13^C NMR, respectively, using an Agilent DD2 600 MHz spectrometer (Agilent, Waldbronn, Germany). Chemical shifts are reported in parts per million (ppm), coupling constants (*J*) are given in Hertz (Hz), and CD~3~CN was used as the solvent.

High-resolution mass spectrometry with electrospray ionization (ESI-HRMS) data were obtained using an LTQ Orbitrap XL instrument (Thermo Fisher Scientific, Bremen, Germany). UV spectra were obtained with a J-750 Spectrophotometer (Jasco, Groß-Umstadt, Germany) in acetonitrile (MeCN).

For circular dichroism (CD) measurements, a J-600 Spectropolarimeter (Jasco, Groß-Umstadt, Germany) with a 0.1-cm cell in MeCN at room temperature was used.

Chemicals and culture media {#Sec4}
---------------------------

Ethyl acetate (EtOAc, analytical grade) was purchased from Grüssing (Filsum, Germany). Cyclohexane (synthesis grade) and MeCN (HPLC grade) were purchased from Roth (Karlsruhe, Germany) and Fisher Scientific (Schwerte, Germany), respectively. Dichloromethane was of analytical grade (Roth, Karlsruhe, Germany). Potato dextrose agar (PDA) was purchased from Sigma-Aldrich, Steinheim, Germany. Dimethyl sulfoxide (DMSO) of bioscience grade was purchased from Roth, Karlsruhe, Germany. Dulbecco's modified Eagle's medium (DMEM) with 4.5 g/L glucose, 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% (*v*/*v*) fetal bovine serum (FBS) was purchased from Gibco, Thermo Fisher, Darmstadt, Germany.

Fungal material, cultivation, extraction and isolation {#Sec5}
------------------------------------------------------

The fungal strain *S. chartarum* DSM 12880 (chemotype S) was purchased from Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). After reviving the freeze-dried culture according to the instruction of the DSMZ, the strain was maintained on slants of PDA medium at 4 °C. Seed cultures were prepared in Erlenmeyer flasks (500 mL) containing 200 mL of liquid PD medium on a laboratory shaker at 150 rpm at 25 °C for 3 days in darkness. The media were autoclaved at 121 °C for 15 min. Petri dishes (92 × 16 mm, Sarstedt, Nümbrecht, Germany) were prepared with PDA for main cultivation, three-point inoculated with 1 mL seed culture, and incubated for 21 days at 25 °C protected from light in an incubator.

After 21 days, the agar plates were extracted exhaustively three times using EtOAc, yielding a crude extract. Afterwards, the crude extract was filtered through Miracloth (Merck, Darmstadt, Germany) to remove spores and agar and evaporated to dryness at 40 °C using a rotary evaporator. The residue was redissolved in dichloromethane, subjected to silica gel column chromatography (CC) (Silica gel 60, 230--400 mesh, Merck, Darmstadt, Germany) and eluted applying a cyclohexane-ethyl acetate gradient of increasing polarity (from 1:0 to 0:1) with 3 mL/min. Fractions were checked by TLC, and similar fractions containing **1**--**3** were combined and further separated and purified by semi-preparative RP-HPLC eluting with 100% MeCN at 4 mL/min to yield **1** (3 mg), **2** (5 mg), and **3** (8 mg).

Cell culture experiments {#Sec6}
------------------------

For the cytotoxicity assay, 20 mM stock solutions and 200-fold concentrations of the used concentration range (0.1--100 μM) of **1**--**3** were prepared in DMSO. These stock solutions were diluted to the respective concentrations with serum containing culture medium. Human hepatic cancer cells (HepG2, ACC 180, DSMZ, Braunschweig, Germany) were cultivated in DMEM using standardized culture conditions (37 °C, 5% CO~2~, saturated humidified atmosphere). For evaluation of cytotoxic effects, the resazurin reduction assay (Alamar Blue assay) based on O'Brien was performed in 96-well plates (O'Brien et al. [@CR27]). Cells were treated with **1**--**3** (0.1--100 μM) and incubated for 24 h, whereas 0.01% (*w*/*v*) saponin from *Quillaja* bark (Sigma-Aldrich, Steinheim, Germany) served as positive control. Viability was calculated after blank subtraction as test over control (T/C). Six replicates of all experiments were performed for each of three independent passages (*n* = 3). The data are presented as the mean ± standard deviation (SD) in Fig. S[22](#MOESM1){ref-type="media"} (Supplementary Material). The IC~50~ and significance values were calculated with OriginPro 2016G (OriginLab Corporation, Northampton, USA): significant at \**p* ≤ 0.05 and highly significant at \*\**p* ≤ 0.01 and \*\*\**p* ≤ 0.001.

Results and discussion {#Sec7}
======================

Isolation and structure elucidation {#Sec8}
-----------------------------------

The filamentous fungus *S. chartarum* DSM 12880 (chemotype S) was cultured on PDA for 3 weeks and extracted with EtOAc. The crude extract was fractionated by silica gel column chromatography and semi-preparative RP-HPLC-UV to yield compounds **1**--**3**.

Stachybotrychromene A (**1**) was isolated as a brownish oil. Its molecular formula was determined to be C~23~H~30~O~3~ by ESI-HRMS (\[M-H\]^−^ *m*/*z* 353.2115, calc. 353.2122), corresponding to the ^1^H and ^13^C NMR data (Table [1](#Tab1){ref-type="table"}) and HSQC spectrum, which indicated nine degrees of unsaturation. The ^13^C and HSQC spectra revealed 23 carbon signals. Briefly, one aldehyde carbon (*δ*~C~ 195.17), six aromatic carbons (*δ*~H~ 161.6, 161.1, 145.7, 114.1, 111.6, 107.6), one oxygen-linked quaternary carbon (*δ*~C~ 81.6), four olefinic carbons (*δ*~C~ 128.0, 125.2, 124.8, 116.1), two quaternary carbons (*δ*~C~ 136.3, 132.2), four methylene groups (*δ*~C~ 42.1, 40.3, 27.3, 23.3), and five methyl groups (*δ*~C~ 27.4, 25.5, 18.4, 17.7, 16.0) (Table [1](#Tab1){ref-type="table"}). The ^1^H NMR spectrum displayed the presence of a phenol proton at *δ*~H~ 12.76 (1H, s, OH-5), an aldehyde proton at *δ*~H~ 10.05 (1H, s, H-22), an aromatic proton at *δ*~H~ 6.20 (1H, s, H-4), and an aromatic methyl group at *δ*~H~ 2.49 (3H, s, H-23). Further examination of the spectrum disclosed a couple of *cis*-configured olefinic protons, *δ*~H~ 6.64 (1H, d, *J* = 10.2 Hz, H-7) and 5.61 (1H, d, *J* = 10.2 Hz, H-8), whereas the characteristic COSY correlation established the partial structure (Fig. [3](#Fig3){ref-type="fig"} and Supplementary Material Fig. S[3](#MOESM1){ref-type="media"}). The HMBC interactions from the olefinic proton at *δ*~H~ 5.61 (H-8) with carbons at *δ*~C~ 107.6 (C-6), 27.4 (C-21), and 42.1 (C-10) and the olefinic proton at *δ*~H~ 6.64 (H-7) with carbons at *δ*~C~ 161.1 (C-1) and 81.6 (C-9) confirmed a chromene moiety attached to a side chain. According to the ^1^H NMR data, this side chain contains four methyl groups; one of them directly linked between the chromene ring and the side chain (*δ*~H~ 1.39 (3H, s, H-21)) as confirmed by HMBC experiments as well. The three remaining methyl groups at *δ*~H~ 1.54 (3H, s, H-20), *δ*~H~ 1.57 (3H, s, H-18), and *δ*~H~ 1.64 (3H, s, H-19), in addition to the two deshielded CH triplets at *δ*~H~ 5.11 (1H, t, *J* = 7.2 Hz, H-12) and *δ*~H~ 5.07 (1H, t, *J* = 7.0 Hz, H-16), imply the presence of an isoprene unit. As assigned from COSY and HMBC resonances, the remaining four methylene signals at *δ*~H~ 1.69 (2H, m, H-10), *δ*~H~ 2.07 (2H, m, H-11), *δ*~H~ 1.94 (2H, m, H-14, overlapped by solvent), and *δ*~H~ 2.03 (2H, m, H-15) completed the structural features of the two prenyl groups derived from the isoprene side chain and concluded the presence of 32 protons in total. The determination of the absolute configuration was not possible, most likely due to tiny impurities adversely affecting the CD properties of the molecule. The compound was designated to be (*E*)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2,7-dimethyl-2H-chromene-8-carbaldehyde.Table 1^1^H and ^13^C NMR data of stachybotrychromenes A--C (**1**--**3**) in CD~3~CN (*δ* in ppm, *J* in Hz)**123**No.*δ*~C~, type*δ*~H~ (*J* in Hz)*δ*~C~, type*δ*~H~ (*J* in Hz)*δ*~C~, type*δ*~H~ (*J* in Hz)1161.1, C161.2, C161.5, C2114.1, C115.9, C113.1, C3145.7, C142.0, C138.8, C4111.6, CH6.20, s111.3, CH6.40, s117.5, CH6.90, s5161.6, C161.2, C160.4, C6107.6, C109.6, C114.0, C7116.1, CH6.64, d (10.2)113.1, CH6.66, d (10.2)115.8, CH6.71, d (10.2)8128.0, CH5.61, d (10.2)129.1, CH5.67, d (10.2)131.8, CH5.82, d (10.2)981.6, C82.0, C82.4, C1042.1, CH~2~1.69, m42.1, CH~2~1.72, m42.1, CH~2~1.77, m1123.3, CH~2~2.07, m23.3, CH~2~2.09, m23.2, CH~2~2.12, m12124.8, CH5.11, t (7.2)124.7, CH5.12, t (7.2)124.6, CH5.12, t (7.2)13136.3, C136.3, C136.5, C1440.3, CH~2~1.94, m40.3, CH~2~1.93, m40.3, CH~2~1.94, m1527.3, CH~2~2.03, m27.3, CH~2~2.02, m27.3, CH~2~2.03, m16125.2, CH5.07, t (7.0)125.2, CH5.07, t (7.0)125.2, CH5.07, t (7.0)17132.2, C132.2, C132.2, C1817.7, CH~3~1.57, s17.8, CH~3~1.57, s17.7, CH~3~1.57, s1925.8, CH~3~1.64, s25.8, CH~3~1.64, s25.8, CH~3~1.64, s2016.0, CH~3~1.54, s16.0, CH~3~1.54, s16.0, CH~3~1.54, s2127.4, CH~3~1.39, s27.5, CH~3~1.41, s27.5, CH~3~1.45, s22195.2, CHO10.05, s194.9, CHO10.01, s196.6, CHO10.63, s2318.4, CH~3~2.49, s63.3, CH~2~5.26, s193.5, CHO10.02, s24171.2, C2521.1, CH~3~2.04, sOH-512.76, s12.72, s12.95, sFig. 3Key ^1^H-^1^H COSY (red lines), HMBC (blue →), and NOE (green ↔) correlations of **1**--**3**

The molecular formula of stachybotrychromene B (**2**) was in accordance with C~25~H~32~O~5~ (ESI-HRMS, \[M-H\]^−^ *m*/*z* 411.2177 (calc. *m*/*z* 411.2175)) and the compound was obtained as brownish oil. The degree of unsaturation was designated to be 10. The analysis of 1D and 2D NMR (HSQC, COSY, and HMBC) data proved **2** to have a similar core structure as described for **1**, with the exception of an acetyl group (*δ*~C~ 171.2 (C-24), *δ*~C~ 21.1 (C-25)/*δ*~H~ 2.04, 3H, s, H-25) replacing the methyl group at C-23 of **1**. The downfield shift of the methylene protons (*δ*~H~ 5.26, 2H, s, H-23) and the respective carbon shift (*δ*~C~ 63.3, C-23) suggest the attachment of the acetyl group to C-23 via an ester bond (Table [1](#Tab1){ref-type="table"}). HMBC resonances between H-25 and C-24, H-23 and C-24, H-4 and C-23, and H-23 and C-2 confirmed the assignment (Fig. [3](#Fig3){ref-type="fig"}). Lastly, an in-source acetate loss (*m*/*z* 351.1960 \[M-CH~3~COOH\]^−^) observed in the ESI-HRMS spectrum established the structure unequivocally (Supplementary Material Fig. S[12](#MOESM1){ref-type="media"}).

The absolute configuration of the stereocenter at C-9 was determined as (*S*) based on the weak but characteristic positive Cotton effect at 260--290 nm observed in the CD spectrum (Fig. [4](#Fig4){ref-type="fig"}), which is in agreement with reported analogues (Li et al. [@CR20]; Bao et al. [@CR2]; Zhang et al. [@CR35]). Therefore, **2** was identified to be (*S*, *E*)-(2-(4,8-dimethylnona-3,7-dien-1-yl)-8-formyl-5-hydroxy-2-methyl-2*H*-chromen-7-yl)methyl acetate.Fig. 4CD spectra of **2** and **3**

Stachybotrychromene C (**3**) was obtained as a yellow oil, and its molecular formula was determined to be C~23~H~28~O~4~ based on ESI-HRMS (\[M-H\]^−^ *m*/*z* 367.1915, calc. 367.1907) and NMR data (Table [1](#Tab1){ref-type="table"}), corresponding to 10 degrees of unsaturation. The ^1^H, ^13^C, HSQC, COSY, and HMBC spectroscopic data are highly comparable to those of **1** and **2**, except for the additional aldehyde group with corresponding signals at *δ*~H~ 10.02 (1-H, s, H-23) and *δ*~C~ 193.5 (C-23) instead of a methyl or acetoxymethylene group, respectively.

Although the chemical shifts of the increment system of the prenyl scaffold of the H-12 proton at *δ*~H~ 5.11 and the C-20 signal *δ*~C~ 16.00 (analogously to **1** and **2**, Table [1](#Tab1){ref-type="table"}) already indicate *E* configuration (Nishino and Bowers [@CR26]; Ma et al. [@CR24]), the configuration of the isoprene unit of **3**, as representative example, was in addition investigated by extensive and selective 1D and 2D NOE experiments. Moreover, the herein presented compounds **1**--**3** are closely related to the recently published stachybonoids A--C (Zhang et al. [@CR35]), which were interestingly described to possess a *cis*-configured isoprene unit. However, selective NOE experiments with saturation on the proton of the C-12 (*δ*~H~ 5.12) enhanced the methylene unit at *δ*~H~ 1.94 (H-14) (Fig. [3](#Fig3){ref-type="fig"} and Supplementary Material Fig. S[18](#MOESM1){ref-type="media"} and Fig. S[19](#MOESM1){ref-type="media"}), thus confirming the *E* configuration of the double bond between C-12 and C-13.

The absolute configuration of the C-9 was also assigned as (*S*) based on CD measurement as described above (Fig. [4](#Fig4){ref-type="fig"}). Hence, the structure was determined to be (*S*, *E*)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2-methyl-2*H*-chromene-7,8-dicarbaldehyde.

Proposed biosynthesis of **1**--**3** and occurrence in other *Stachybotrys* strains {#Sec9}
------------------------------------------------------------------------------------

Meroterpenoids are hybrid biosynthesized natural products, partially derived from terpenoids (Geris and Simpson [@CR10]). Regarding compounds **1**--**3**, this hybrid structure is comprised of an additional tetraketide part. Key intermediate is *o*-orsellinic acid (OA), which is formed from acetyl-CoA and 3 units of malonyl-CoA after cyclization. Afterwards, a prenylation step leads to the attachment of the prenyl side chain and the carboxy function of OA undergoes reduction to an aldehyde group to form LL-Z1272β, also known as ilicicolin B (Li et al. [@CR21]). This compound is well known as a key intermediate within the biosynthetic pathway of many meroterpenoids and is therefore assumed to be the precursor for compounds **1**--**3**.

Ultimately, **1** bears the aromatic methyl group at C-23, derived from *o*-orsellinaldehyde, which is further transformed into an oxidized acetoxymethylene group yielding **2**. Subsequently, the final oxidation at C-23 leads to the formation of **3**, possessing the respective aldehyde group. HPLC-MS/MS analysis of the metabolic profile of *S. chartarum* (DSM 12880) showed that **1** and **2** are the main compounds formed during the first days of incubation. The signals of **1** and **2** decrease over time and **3** occurs as the major compound at later time points (data not shown). Thus, **1** and **2** are most likely intermediates, whereas **3** is the final product within this biosynthetic pathway. These observations are in agreement with reported (proposed) biosynthetic pathways of other meroterpenoids among the genus *Stachybotrys* (Zhang et al. [@CR35]; Zhao et al. [@CR38]).

**1**--**3** are produced by a diversity of *Stachybotrys* strains. Within metabolite profiling, it was observed that also *S. chartarum* chemotype A (IBT 40288, CBS 109291), S (IBT 40293, CBS 109290), and *Stachybotrys chlorohalonata* (IBT 40285, CBS 109283) are capable producers, as well on different media, such as malt extract agar. Only *S. chartarum* DSMZ 63425 appeared with a different profile, and no stachybotrychromenes were detected (data not shown).

Cytotoxicity {#Sec10}
------------

For assessment of cytotoxic effects, compounds **1**--**3** were tested on HepG2 cells, using the resazurin reduction assay. For compound **1**, the results indicated that cell viability is significantly reduced with treatment of 50 μM (*p* \< 0.05) after 24 h of incubation. Compound **2** was more potent and showed significantly reduced cell survival rates at 25 μM (p \< 0.05), whereas for compound **3**, no significantly reduced cell viability up to 100 μM was observed (Supplementary Material, Fig. S[22](#MOESM1){ref-type="media"}). For **1** and **2**, IC~50~ values were determined to be 73.7 and 28.2 μM, respectively.

Due to the fact that chromenes and chromanes have been reported to possess antiprotozoal and antiviral properties (Harel et al. [@CR11]; Li et al. [@CR20]; Presley et al. [@CR30]), further investigations regarding those biological activities of the newly isolated compounds might be of interest.

The present work discovered three novel meroterpenoid derivatives (**1**--**3**), named stachybotrychromenes A--C, isolated from *S. chartarum* DSM 12880 (chemotype S) containing a chromene ring backbone structure with an attached isoprenoid side chain. In view of the biosynthetic pathway, it can be assumed that **3** is the final product and is biosynthesized via the intermediates **1** and **2**. In terms of cytotoxicity, **1** and **2** showed moderate cytotoxic effects on HepG2 cells after 24 h of exposure, whereas **3** exhibited no cytotoxicity within the investigated concentration range (0.1--100 μM). It should be noticed that these compounds are produced by both chemotypes of *S. chartarum* as well as *S. chlorohalonata* and contribute to the toxic profile of this genus.
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